美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Medicus Pharma Ltd.

3.62

-0.9850-21.39%

成交量：8.85万

成交额：35.14万

市值：457.43万

市盈率：-0.04

高：4.69

开：4.20

低：3.61

收：4.61

52周最高：139.00

52周最低：3.61

股本：126.36万

流通股本：93.37万

量比：0.02

换手率：9.47%

股息：- -

股息率：- -

每股收益(TTM):-82.9844

每股收益(LYR):-136.7796

净资产收益率：-7446.11%

总资产收益率：-110.67%

市净率：-2.59

市盈率(LYR):-0.03

数据加载中...

总览公司新闻资讯公告

Medicus Pharma向FDA提交优化版Teverelix®注册方案，为晚期前列腺癌打造合作就绪项目

Medicus Pharma宣布Skinject®在戈林综合征领域的独家开发重点，经商业、临床及监管全面评估后敲定

Medicus Pharma宣布终止与Yorkville的备用股权购买协议，9月11日生效——SEC文件披露

Medicus Pharma发布Skinject®二期临床试验最终报告摘要：确认200ΜG D-Mna贴片为主要研发剂量

MEDICUS PHARMA股价下跌29.8%；公司与辉瑞就实验性癌症疗法达成授权协议。

BUZZ——美国股市动态-黄金矿企、极星汽车、英伟达

Medicus Pharma盘前股价大跌20.5%，与辉瑞达成实验性癌症疗法授权协议

Medicus Pharma股价飙升，因与辉瑞达成实验性癌症疗法授权协议

Medicus Pharma于2026年9月2日与辉瑞签署共同开发及许可协议——SEC文件披露

新闻稿：Medicus Pharma 任命 Faisal Mehmud 博士为英国子公司 Antev Limited 首席执行官

Medicus Pharma任命DR. Faisal Mehmud为英国Antev Limited首席执行官

Medicus Pharma获阿联酋卫生部门批准，推进Teverelix Precision-E2 2a期临床研究

Medicus Pharma 获FDA批准：针对戈林综合征患者的Skinject®关键注册研究可启动

Medicus Pharma获FDA积极反馈及中心IRB批准，开展优化版Teverelix®治疗急性尿潴留二期新研究

Medicus Pharma宣布向美国食品药品监督管理局提交Skinject®用于戈林综合征的罕见儿科疾病认定申请

Medicus Pharma启动基于阿联酋基因组计划的突破性Teverelix®治疗子宫内膜异位症的Precision-E2 IIa期研究

Medicus Pharma推进Teverelix®项目进入注册开发阶段，针对高心血管风险前列腺癌患者完成关键欧洲提交

Medicus Pharma公布预设扩展二期Sknjct-003数据分析结果显示显著剂量效应

Medicus Pharma Ltd. 旗下D-Mna展现良好安全性特征未出现药物相关严重不良事件

Medicus制药公司提交SEC文件：拟通过代理机构发行不超过5000万美元普通股

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/MDCX/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":3.62,"timestamp":1791827220257,"preClose":4.605,"halted":0,"volume":88453,"delay":0,"changeRate":-0.2138979370249729,"floatShares":933733,"shares":1263612,"eps":-82.98445,"marketStatus":"交易中","change":-0.985,"latestTime":"10-12 13:47:13 EDT","open":4.2,"high":4.69,"low":3.61,"amount":351439.76130240003,"amplitude":0.234528,"askPrice":3.67,"askSize":500,"bidPrice":3.6,"bidSize":295,"shortable":0,"etf":0,"ttmEps":-82.98445,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791835200000},"marketStatusCode":2,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":4.605,"preHourTrading":{"tag":"盘前","latestPrice":4.61,"preClose":4.605,"latestTime":"09:17 EDT","volume":61,"amount":281.1500004,"timestamp":1791811076387,"change":0.005,"changeRate":0.001086,"amplitude":0.013029},"postHourTrading":{"tag":"盘后","latestPrice":0.0845,"preClose":0.0921,"latestTime":"19:48 EDT","volume":822943,"amount":69535.101189,"timestamp":1791589684762,"change":-0.0076,"changeRate":-0.082519,"amplitude":0.114007},"volumeRatio":0.016948},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":933733,"roa":"-110.67%","roe":"-7446.11%","lyrEps":-136.77965,"volumeRatio":0.016948,"shares":1263612,"dividePrice":0,"high":4.69,"amplitude":0.234528,"preClose":4.605,"low":3.61,"week52Low":3.61,"pbRate":"-2.59","week52High":139,"institutionHeld":0,"latestPrice":3.62,"committee":-0.257862,"eps":-82.98445,"divideRate":0,"volume":88453,"delay":0,"ttmEps":-82.98445,"open":4.2,"prevYearClose":76.5,"prevWeekClose":4.605,"prevMonthClose":8.05,"prevQuarterClose":8.05,"fiveDayClose":8.35,"twentyDayClose":7.965,"sixtyDayClose":18.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-10-12","symbol":"MDCX","defaultRemindTime":1791811800000,"type":"split","dateTimestamp":1791777600000,"forFactor":50,"toFactor":1,"ratio":50},{"market":"US","date":"2026-08-12","symbol":"MDCX","fiscalQuarterEnding":"2026/06","expectedEps":-0.14,"name":null,"time":"盘后","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2026-05-14","symbol":"MDCX","fiscalQuarterEnding":"2026/03","expectedEps":-0.18,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2026-03-25","symbol":"MDCX","fiscalQuarterEnding":"2025/12","expectedEps":-0.32,"name":null,"time":"盘后","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.82},{"date":"2025-11-14","symbol":"MDCX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763154000000,"name":null,"time":"盘后","dateTimestamp":1763096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1785297600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MDCX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MDCX","date":"2026-10-09","current":-0.045069,"percent":1,"low":-3.23298,"twenty":-2.080362,"median":-0.492235,"eighty":-0.299392,"high":-0.113621,"avg":-1.012929,"sd":0.942974,"marketCap":6438104},"quantilePoints":[{"date":"2025-08-29","current":-2.084531,"twenty":-2.272139,"median":-2.126221,"eighty":-2.109545,"marketCap":35632532},{"date":"2025-09-05","current":-1.907346,"twenty":-2.205434,"median":-2.115799,"eighty":-2.053263,"marketCap":32603766},{"date":"2025-09-12","current":-2.345097,"twenty":-2.211687,"median":-2.12101,"eighty":-2.053263,"marketCap":40086598},{"date":"2025-09-19","current":-2.532705,"twenty":-2.511859,"median":-2.178335,"eighty":-2.080362,"marketCap":43293526},{"date":"2025-09-26","current":-2.817408,"twenty":-2.759151,"median":-2.287772,"eighty":-2.103292,"marketCap":48160186},{"date":"2025-10-03","current":-3.005474,"twenty":-2.869667,"median":-2.511859,"eighty":-2.115799,"marketCap":51374941},{"date":"2025-10-10","current":-3.005474,"twenty":-2.994879,"median":-2.558762,"eighty":-2.122052,"marketCap":51374941},{"date":"2025-10-17","current":-2.885734,"twenty":-2.976858,"median":-2.720313,"eighty":-2.151236,"marketCap":49328130},{"date":"2025-10-24","current":-2.909682,"twenty":-2.974342,"median":-2.774974,"eighty":-2.174166,"marketCap":49737492},{"date":"2025-10-31","current":-2.957578,"twenty":-2.974342,"median":-2.817408,"eighty":-2.178335,"marketCap":50556216},{"date":"2025-11-07","current":-2.897708,"twenty":-2.962368,"median":-2.809662,"eighty":-2.228364,"marketCap":49532811},{"date":"2025-11-14","current":-2.706124,"twenty":-2.950394,"median":-2.817408,"eighty":-2.292984,"marketCap":46257915},{"date":"2025-11-21","current":-1.28141,"twenty":-2.950394,"median":-2.789942,"eighty":-2.178335,"marketCap":44939453},{"date":"2025-11-28","current":-1.355609,"twenty":-2.936025,"median":-2.763,"eighty":-2.119968,"marketCap":48464116},{"date":"2025-12-05","current":-1.183077,"twenty":-2.916866,"median":-2.742046,"eighty":-2.04284,"marketCap":42295956},{"date":"2025-12-12","current":-1.201563,"twenty":-2.904892,"median":-2.700137,"eighty":-1.376181,"marketCap":42956830},{"date":"2025-12-19","current":-1.022869,"twenty":-2.897708,"median":-2.63428,"eighty":-1.31987,"marketCap":36568379},{"date":"2025-12-26","current":-0.955088,"twenty":-2.897553,"median":-2.584818,"eighty":-1.266827,"marketCap":34145173},{"date":"2026-01-02","current":-1.074791,"twenty":-2.896932,"median":-2.511859,"eighty":-1.220048,"marketCap":38424640},{"date":"2026-01-09","current":-1.095865,"twenty":-2.885734,"median":-2.329463,"eighty":-1.179996,"marketCap":39178064},{"date":"2026-01-16","current":-0.976444,"twenty":-2.885734,"median":-2.178335,"eighty":-1.123965,"marketCap":34908660},{"date":"2026-01-23","current":-0.94132,"twenty":-2.866576,"median":-2.167912,"eighty":-1.101485,"marketCap":33652952},{"date":"2026-01-30","current":-0.878097,"twenty":-2.861786,"median":-2.115799,"eighty":-1.061072,"marketCap":31392680},{"date":"2026-02-06","current":-0.765701,"twenty":-2.861786,"median":-2.074108,"eighty":-1.022014,"marketCap":27374416},{"date":"2026-02-13","current":-0.709738,"twenty":-2.853549,"median":-1.933403,"eighty":-0.974021,"marketCap":25373688},{"date":"2026-02-20","current":-0.786136,"twenty":-2.850483,"median":-1.381324,"eighty":-0.961937,"marketCap":28104981},{"date":"2026-02-27","current":-0.97195,"twenty":-2.849812,"median":-1.344224,"eighty":-0.949581,"marketCap":34747976},{"date":"2026-03-06","current":-0.484474,"twenty":-2.849812,"median":-1.300152,"eighty":-0.949581,"marketCap":17320333},{"date":"2026-03-13","current":-0.412761,"twenty":-2.835443,"median":-1.263181,"eighty":-0.891018,"marketCap":14756541},{"date":"2026-03-20","current":-0.412761,"twenty":-2.825864,"median":-1.220048,"eighty":-0.847322,"marketCap":14756541},{"date":"2026-03-27","current":-0.387698,"twenty":-2.82079,"median":-1.201563,"eighty":-0.836077,"marketCap":18330934},{"date":"2026-04-02","current":-0.349652,"twenty":-2.811211,"median":-1.179996,"eighty":-0.820403,"marketCap":16532085},{"date":"2026-04-10","current":-0.367967,"twenty":-2.792337,"median":-1.125793,"eighty":-0.786136,"marketCap":17398052},{"date":"2026-04-17","current":-0.250001,"twenty":-2.775573,"median":-1.109135,"eighty":-0.744685,"marketCap":11820441},{"date":"2026-04-24","current":-0.276475,"twenty":-2.764797,"median":-1.099378,"eighty":-0.508201,"marketCap":13072156},{"date":"2026-05-01","current":-0.235266,"twenty":-2.75402,"median":-1.088841,"eighty":-0.417566,"marketCap":11123732},{"date":"2026-05-08","current":-0.277717,"twenty":-2.74923,"median":-1.069002,"eighty":-0.412761,"marketCap":13130880},{"date":"2026-05-15","current":-0.393186,"twenty":-2.733353,"median":-1.041354,"eighty":-0.401798,"marketCap":18590424},{"date":"2026-05-22","current":-0.308017,"twenty":-2.714637,"median":-1.024243,"eighty":-0.38811,"marketCap":15777036},{"date":"2026-05-29","current":-0.354651,"twenty":-2.703729,"median":-1.018593,"eighty":-0.376126,"marketCap":18165658},{"date":"2026-06-05","current":-0.402361,"twenty":-2.691755,"median":-0.976444,"eighty":-0.374724,"marketCap":20609444},{"date":"2026-06-12","current":-0.35842,"twenty":-2.672597,"median":-0.968141,"eighty":-0.372398,"marketCap":18358733},{"date":"2026-06-18","current":-0.378775,"twenty":-2.63428,"median":-0.962395,"eighty":-0.367967,"marketCap":19401342},{"date":"2026-06-26","current":-0.492235,"twenty":-2.63428,"median":-0.955088,"eighty":-0.371628,"marketCap":25212882},{"date":"2026-07-02","current":-0.442458,"twenty":-2.59471,"median":-0.94132,"eighty":-0.37203,"marketCap":22663265},{"date":"2026-07-10","current":-0.467347,"twenty":-2.543128,"median":-0.915037,"eighty":-0.3732,"marketCap":23938074},{"date":"2026-07-17","current":-0.449095,"twenty":-2.516028,"median":-0.871896,"eighty":-0.374395,"marketCap":23003214},{"date":"2026-07-24","current":-0.424981,"twenty":-2.511859,"median":-0.846653,"eighty":-0.374627,"marketCap":21768066},{"date":"2026-07-31","current":-0.290474,"twenty":-2.411802,"median":-0.843141,"eighty":-0.371929,"marketCap":14878433},{"date":"2026-08-07","current":-0.34025,"twenty":-2.326336,"median":-0.835949,"eighty":-0.363051,"marketCap":17428051},{"date":"2026-08-14","current":-0.353971,"twenty":-2.282561,"median":-0.821824,"eighty":-0.360424,"marketCap":20056990},{"date":"2026-08-21","current":-0.30351,"twenty":-2.211687,"median":-0.793282,"eighty":-0.354379,"marketCap":17197762},{"date":"2026-08-28","current":-0.298604,"twenty":-2.178335,"median":-0.778989,"eighty":-0.346389,"marketCap":16919767},{"date":"2026-09-04","current":-0.190112,"twenty":-2.172081,"median":-0.757549,"eighty":-0.339549,"marketCap":10772294},{"date":"2026-09-11","current":-0.179965,"twenty":-2.151236,"median":-0.709738,"eighty":-0.335,"marketCap":10197350},{"date":"2026-09-18","current":-0.190224,"twenty":-2.122052,"median":-0.541685,"eighty":-0.329543,"marketCap":10778612},{"date":"2026-09-25","current":-0.177066,"twenty":-2.115799,"median":-0.506615,"eighty":-0.313898,"marketCap":10033080},{"date":"2026-10-02","current":-0.175059,"twenty":-2.103292,"median":-0.499977,"eighty":-0.305853,"marketCap":9919355},{"date":"2026-10-09","current":-0.113621,"twenty":-2.080362,"median":-0.492235,"eighty":-0.299392,"marketCap":6438104}],"updateTime":1791825234772},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1151980042","title":"Medicus Pharma向FDA提交优化版Teverelix®注册方案，为晚期前列腺癌打造合作就绪项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1151980042","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151980042?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 19:31","pubTimestamp":1790681494,"startTime":"0","endTime":"0","summary":"Medicus Pharma向FDA提交优化版Teverelix®注册方案，为晚期前列腺癌打造合作就绪项目","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189169859","title":"Medicus Pharma宣布Skinject®在戈林综合征领域的独家开发重点，经商业、临床及监管全面评估后敲定","url":"https://stock-news.laohu8.com/highlight/detail?id=1189169859","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189169859?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 19:31","pubTimestamp":1789990276,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.近日正式宣布，将Skinject的开发方向独家聚焦于戈林综合征适应症。这一战略决策是在对商业前景、临床证据及监管路径进行系统评估之后作出的，标志着公司在该罕见病领域的资源投入进一步集中与深化。综合考量后，管理层认定戈林综合征是Skinject最具差异化优势的开发赛道。Medicus Pharma认为，Skinject有望填补这一治疗空白，为该患者群体带来新的选择。Medicus Pharma此番战略调整，展现出其对研发管线的审慎梳理与长期布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135292318","title":"Medicus Pharma宣布终止与Yorkville的备用股权购买协议，9月11日生效——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1135292318","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135292318?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 20:08","pubTimestamp":1789387690,"startTime":"0","endTime":"0","summary":"Medicus Pharma近日向美国证券交易委员会（SEC）提交文件，正式宣布终止其与Yorkville签订的一项备用股权购买协议。据悉，该协议的终止将在2026年9月11日正式生效。此举标志着两家机构之间现有融资安排画上了句号。文件内容简明扼要，未详细说明终止的具体原因，但已引发市场对该公司后续资本运作策略的广泛猜测。Medicus Pharma这一决定，无疑将为公司未来的财务路径增添新的变数与看点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131081188","title":"Medicus Pharma发布Skinject®二期临床试验最终报告摘要：确认200ΜG D-Mna贴片为主要研发剂量","url":"https://stock-news.laohu8.com/highlight/detail?id=1131081188","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131081188?lang=zh_cn&edition=fundamental","pubTime":"2026-09-10 19:32","pubTimestamp":1789039958,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.近日公布了其Skinject二期临床试验的最终临床研究报告摘要，这一里程碑式的成果明确了200ΜG D-Mna贴片作为主导研发剂量的地位。作为一家专注于皮肤科创新疗法的生物制药企业，Medicus Pharma此次公布的结果或将对其未来的注册临床试验设计产生深远影响。该CSR摘要的发布，无疑为投资者和医学界观察这一候选药物的进展提供了关键的参考节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664687724","title":"MEDICUS PHARMA股价下跌29.8%；公司与辉瑞就实验性癌症疗法达成授权协议。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664687724","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664687724?lang=zh_cn&edition=fundamental","pubTime":"2026-09-03 21:42","pubTimestamp":1788442933,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BBT3K403.USD","BK4550","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU0306807586.USD","SG9999001176.SGD","LU2596442595.SGD","LU0985481810.HKD","SG9999002224.SGD","BK4534","BK4139","BK4599","LU0321505439.SGD","LU1894683264.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","LU1066053197.SGD","LU0170899867.USD","LU1057294990.SGD","SG9999013999.USD","BK4581","LU0225284248.USD","LU1066051498.USD","LU0456855351.SGD","BK4007","SGXZ57979304.SGD","MDCX","IE00BLSP4452.SGD","BK4568","LU0122379950.USD","LU0225771236.USD","BK4533","LU1883839398.USD","IE0002270589.USD","IE00BLSP4239.USD","SG9999011175.SGD","IE00B3T34201.USD","BK4588","BK4585","LU0234572021.USD","LU0868494617.USD","LU0289739699.SGD","PFE","SG9999001176.USD","SG9999002232.USD","OZEM","LU0321505868.SGD","BK4592","LU1023059063.AUD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664785872","title":"BUZZ——美国股市动态-黄金矿企、极星汽车、英伟达","url":"https://stock-news.laohu8.com/highlight/detail?id=2664785872","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664785872?lang=zh_cn&edition=fundamental","pubTime":"2026-09-03 21:07","pubTimestamp":1788440862,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-黄金矿企、极星汽车、英伟达工作区中用于查询单只股票行情的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》通讯：https://refini.tv/3dKUyB8路透9月3日-受企业财报喜忧参半以及投资者持续关注中东局势影响，标普500指数和纳斯达克100指数周四开盘预计将表现平淡。.N** Snowflake In","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4S44V127:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","ILIT","LU2462591277.SGD","IE00BJLML261.HKD","LU0081259029.USD","LU1718418525.SGD","LU1861220033.SGD","LU1144417596.USD","LU2092627202.USD","LU1316542783.SGD","LU2394011477.USD","LU2954938101.SGD","IE00BD6J9T35.USD","HK0000819398.USD","LU0882574139.USD","LU1037948897.HKD","LU2462591350.SGD","SETM","SG9999014914.USD","LU2491049909.HKD","NVIW.SI","LU2746668974.SGD","LU0079474960.USD","LU0823434740.USD","CLOD","LU2764262908.HKD","BK4585","LU0097036916.USD","LU2361044949.HKD","LU0300736492.USD","LU0949170772.SGD","LU2065171311.SGD","LU0320765646.SGD","LU0426417589.USD","LU0055631609.USD","GFI","LU0345781412.USD","LU0122379950.USD","LU2168564495.EUR","SNOY","LU1934455194.USD","BK4550","AUMI","LU1691799644.USD","LU2506951792.HKD","SG9999003800.SGD","DIPS","LU0689472784.USD","LU2100268510.USD","SG9999015358.SGD","LU1242518931.SGD","HK0000304797.USD","LU0823434583.USD","LU2498475776.HKD","LU2237438978.USD","LU0719512351.SGD","LU2452424414.USD","LU0477156797.USD","ARTY","LU0823421333.USD","BK4141","LU2346227817.USD","LU2249611893.SGD","LU1791710400.SGD","LU1894683264.USD","IE00BD4GTV84.USD","IE0034235188.USD","LU1861127337.USD","LU0211327993.USD","LU1430597077.USD","BK4607","LU1935043023.USD","LU2168564222.USD","LU0266013472.USD","LU2347655156.SGD","SG9999014559.SGD","LU2381873111.SGD","SGXZ31699556.SGD","LU1023059493.AUD","LU0323239441.USD","LU0075056555.USD","LU0868494617.USD","LU1935043536.SGD","LU0823421416.USD","NVDG","LU0077335932.USD","LU0225283273.USD","LU2125909593.SGD","IE0004445015.USD","LU0648001328.SGD","LU1992135399.USD","LU0006306889.USD","BK4554","LU0889566641.SGD","LU1102505762.USD","IE00B19Z8X17.USD","LU2756315664.SGD","IE00BK4W5M84.HKD","BK4568","LU2360107168.USD","BK4587","LU0096362180.USD","NOWL","LU0511384066.AUD","IE00BK4W5L77.USD","LU0612318971.USD","LU2106854487.HKD","LU2602419157.SGD","NVDD","IE00B19Z8W00.USD","NVDU","LU2456880835.USD","BK4527","LU0788109477.HKD","FTEC","LU1023059063.AUD","CHAT","LU1066051225.USD","LU2108987350.USD","LU1400636491.USD","SG9999002232.USD","IE00B3SWFQ91.USD","LU2403377893.USD","LU2491050154.USD","SG9999015978.USD","LU1839511570.USD","LU0308772762.SGD","BK4535","IE0034235295.USD","LU1852331112.SGD","LU2125154935.USD","LU2317271919.USD","BK4097","LU2087625088.SGD","TRFK","IE00BFSS8Q28.SGD","LU0724618789.USD","IE00B3M56506.USD","IE00BVYPNW00.USD","LU2360107325.USD","SNOW","09788","LU0215105999.USD","IE00B4JS1V06.HKD","IE00B5TLWC47.USD","LU2462611646.USD","IE00B66KJ199.SGD","LU2237443978.SGD","LU2250418816.HKD","LU0143551892.USD","LU0708994859.HKD","LU0133085943.USD","LU0069063385.USD","BK4551","ALBG","GB00BDT5M118.USD","LU2092937148.SGD","LU2430703251.USD","LU1035773651.USD","BK4109","LU2764263203.CNY","LU2210149790.SGD","HK0000532082.HKD","GPZ","NVDQ","SPTE","LU1548497426.USD","AVGW","LU0456855351.SGD","LU2089985449.USD","CPB","LU0477156953.USD","AVL","LU0289739343.SGD","LU2211815571.USD","LU2505996681.GBP","LU1814569148.SGD","LU2089284900.SGD","LU1989764748.USD","SG9999001176.SGD","LU2047632596.USD","HAKY","LU1935042488.USD","IE0005OL40V9.USD","SNPE","IE00B7SZL793.SGD","LU0057025933.USD","LU0124676726.USD","LU2286300806.USD","LU0788108826.HKD","LITP","LU0289960550.SGD","LU0210533765.USD","LU0300736062.USD","LU2326559502.SGD","NULC","AUAU","LU1201861249.SGD","CLOU","LU0498741890.SGD","USXF","LU2065171402.SGD","LU2420271590.USD","LU0096364046.USD","BK4613","LU1496350502.SGD","NOW","IE00B894F039.SGD","LU0672654240.SGD","TTXU","LU1223082196.USD","DAT","LU0965509283.SGD","SMH","LU1244550577.SGD","LU2213496289.HKD","BK4566","LU1267930813.SGD","LU0792757196.USD","LU0170899867.USD","LU1323610961.USD","IE00BGHQDM52.EUR","LU0320765059.SGD","LU2087621335.USD","LU0345769128.USD","LU1366192091.USD","LU1861219969.SGD","LU1883839398.USD","LU2543165471.USD","LU1732800096.USD","LU0957808578.USD","ADBG","LU0234570918.USD","GAMR","IE00B5949003.HKD","LU1116320901.HKD","BK4581","LU1934455277.USD","IE00BJTD4N35.SGD","LU2125909247.SGD","LU2458330243.SGD","TRUM","SG9999014567.USD","LU0612318385.USD","SG9999015986.USD","IE00B1BXHZ80.USD","CGDG","LU0158827781.USD","IE00BFXG0V08.USD","LU1267930573.SGD","LU1883866441.USD","LU0348723411.USD","LU2505996509.AUD","LU0052756011.USD","SG9999014898.SGD","LU0106261372.USD","HK0000306685.HKD","SG9999014542.SGD","LU2279689827.SGD","LU2097344431.USD","LU0965509101.SGD","BK4211","SG9999015341.SGD","LU0788109121.HKD","LU1989764664.SGD","LU0130102774.USD","INTU","VGT","IE00B1XK9C88.USD","LU0256863902.USD","HK0000914660.USD","SNVDAmain","AVGG","BK4608","LU1951198990.SGD","LU0345769631.USD","LU0368265764.SGD","CRMG","LU0109391861.USD","LU1670627923.USD","LU1116320737.USD","LU0266512127.USD","LU2148611432.USD","NVDS.UK","IE00B19Z9505.USD","LU1712237335.SGD","LU1435385759.SGD","LU0187121727.USD","THMR","SG9999011175.SGD","LU1046421795.USD","EFIV","LU2168563687.JPY","LU2322448957.HKD","LU0345780281.USD","LU0225284248.USD","IE0009356076.USD","SGXZ57979304.SGD","ABFL","BK4545","AFK","LU0006061336.USD","LU0861579265.USD","LU2133065610.SGD","LU2065169927.USD","HK0000914686.HKD","CIBR","FMTL","LU1267930227.SGD","LU0127658192.USD","ROM","IE00B19Z4B17.USD","LU2063271972.USD","LU2750360997.AUD","3NVD.UK","LU0345774391.USD","LU2360032135.SGD","CGBL","SGDM","LU0345780521.USD","LU0640476718.USD","LU2322448791.USD","IE00BN8TJ469.HKD","BAI","AIPI","LU0742534661.SGD","IE00BMPRXN33.USD","LU0395794307.EUR","LU1280957306.USD","LU0345780950.USD","LU1670711040.USD","IE00BFSS7M15.SGD","RARE","LU0175139822.USD","LU0786609619.USD","LU2097344357.USD","SNVD.UK","LU0138981039.USD","LU0528227936.USD","LU0390134368.USD","LU0784383803.USD","LU0323591593.USD","IE00BQXX3F31.USD","LU0738911758.USD","AMAL","IE00BDRTCR15.USD","LU0498741114.HKD","IE00BDGV0183.EUR","CNEQ","LU1153585028.USD","LU1951200564.SGD","LU0784385840.USD","LU1242518857.USD","BK4592","LU1778281490.HKD","SG9999013999.USD","LU2023250843.SGD","LU0316494557.USD","LU2592432038.USD","LU1301847155.USD","NVDL","LU2552382215.SGD","NVDS","LU2430703095.HKD","IE00BWXC8680.SGD","LU1261432733.SGD","HK0000320223.HKD","NVYY","LU2360108059.USD","ILDR","IE00BYV24P56.USD","BK4561","LU0198837287.USD","LU2237443465.HKD","IE00BZ199S13.USD","LU1804176565.USD","LU2473716301.USD","LU2023250330.USD","LU1670710661.SGD","LU0795875086.SGD","LU1429558221.USD","LU0345774631.USD","LU1791710582.SGD","LU1917777945.USD","LU1974910355.USD","LU2028103732.USD","SG9999001176.USD","LU1878469433.USD","SG9999018865.SGD","LU0965509010.AUD","LU0056508442.USD","LU2092937221.SGD","LU2931357623.SGD","LU2290526834.HKD","SG9999015952.SGD","BK4538","LU1645745479.HKD","LU1868837136.USD","LU2347655073.USD","LU2242650005.HKD","LU1366333091.USD","LU0795875169.SGD","LIMI","LU2237443382.USD","LU1923623000.USD","LU1069347547.HKD","FDTX","IE00B3QW5Z07.USD","BK4570","LU1732799900.SGD","IE00B3PB1722.GBP","LU0557290698.USD","LU2746668461.USD","NVDB","LU0128525929.USD","LU1992135472.HKD","IE00B19Z9Z06.USD","LU0306806265.USD","LU1551013425.SGD","LU1861215975.USD","BK4605","BK4549","AGMI","IE000KEQY171.SGD","SG9999004303.SGD","TYLG","JGRO","LU1066051811.HKD","BK4548","LU1043141123.HKD","LU1066051498.USD","LU0061475181.USD","IXN","LU0820561818.USD","GDX","BK4598","LU2236285917.USD","LU2471134879.HKD","LU1162221912.USD","BK4529","TDIV","LU2054465674.USD","BK4567","AIFD","SOXX","BK4017","IE00BJJMRX11.SGD","LU0289961442.SGD","LU1201861165.SGD","LU2237443895.HKD","LU0342679015.USD","LU0942090050.USD","SG9999015945.SGD","ESLG","LU0466842654.USD","IE00BKPKM429.USD","LU1400636657.SGD","SG9999000418.SGD","LU1989772923.USD","LFGY","PSP","LU0476273544.USD","CLYM","LU2896262040.SGD","IE00BJJMRY28.SGD","IE00BZ9MQY76.HKD","LU1935042991.SGD","LU2264538146.SGD","LU0310800965.SGD","NEMG","LU0265550946.USD","BK4023","SG9999014906.USD","SGXZ99366536.SGD","LU0912757837.SGD","LU2247934214.USD","SOXY","BK4539","LU0251142724.SGD","BK4116","LU0265550359.USD","MDCX","IE00B42XCP33.USD","IE00BLSP4452.SGD","NVII","LU0708995401.HKD","LU0354030438.USD","LU1236620834.HKD","CLSE","LU2265009873.SGD","LU2357305700.SGD","LU1127390331.HKD","LU2294711713.HKD","BK4614","LU2357125470.USD","LU2361044865.SGD","IE000Q6AESB8.SGD","07388","LU0444971666.USD","BK4212","LU0310799852.SGD","USD","LU0080751232.USD","VT","LU1821325948.USD","LU2237957902.USD","LU1868838027.USD","PSNY","SAVGOmain","LU0154236417.USD","LU0128525689.USD","SG9999014575.USD","LU0417517546.SGD","LU0303823156.USD","LU1670711123.USD","BK4170","AGOX","LU0158827948.USD","IE00B3T34201.USD","LU1823568750.SGD","LU2168564149.EUR","LU2125909916.SGD","IE00BJTD4V19.USD","IE00B19Z3B42.SGD","IE000W1ABFV2.USD","NVDW","LU0724617625.USD","LU2210150020.SGD","WISE","NEM","LIT","LU0965508806.USD","LU1670628061.USD","LU0143863198.USD","LU2462157665.USD","METV","SG9999001440.SGD","LU2065170008.USD","LU0048584097.USD","IE00BVYPNV92.GBP","LU0353189763.USD","LU2041044095.USD","LU2720916845.USD","IE00BMPRXR70.SGD","BK4534","IE00BD4GTT62.SGD","LU0784385170.HKD","LU0058720904.USD","BK4528","LU0985481810.HKD","LU1232071149.USD","LU0251132253.USD","PFE","BK4503","XDAT","LU1670756490.USD","LU2361045086.USD","LU0306807586.USD","BK4522","LU0314104364.USD","IE00BGHQF631.EUR","LU2999663052.SGD","LU0210536198.USD","LU1102505929.USD","GDMN","LU1202635105.USD","LU1043141396.HKD","LU1069344957.HKD","ANV","LU1496350171.SGD","LU0238689110.USD","IE000M9KFDE8.USD","IE0009G5SDU7.USD","IE00BVYPNP33.GBP","LU0266512473.USD","LU0456854461.SGD","LU1721428933.USD","LU2433249047.HKD","LU2023250504.SGD","LU2764263039.SGD","SGXZ81514606.USD","LU0174119429.USD","LU0094547139.USD","NVDX","LU0203347892.USD","LU0203201768.USD","LU0267386448.USD","ADBE","CGGO","LU1815336760.USD","NVD","LU0321505868.SGD","LU1223082519.USD","2NVD.UK","CHPX","LU1145028129.USD","LU2048586759.USD","LU0820562030.AUD","NVDY","SGXZ51526630.SGD","LU0321505439.SGD","LU2458330169.SGD","DLTH","LU0053666078.USD","LU0011850046.USD","BK4099","LU0234572021.USD","LU2430703178.SGD","IE00B19Z3581.USD","LU2413666699.HKD","IE00B775H168.HKD","LU0210528500.USD","LU0353189680.USD","LU0545039389.USD","LU1003077747.HKD","LU1244550221.USD","LU0157215616.USD","LU0345770993.USD","IE00BMCWC346.EUR","LU0256863811.USD","LU0289739699.SGD","AU","LU1815333072.USD","LU2023251221.USD","LU0553294199.USD","HK0000304805.HKD","LU2360106780.USD","IE00BKDWB100.SGD","LU2461242641.AUD","HK0000306701.USD","IE00B19Z9P08.USD","IE0004445239.USD","IE00BKVL7J92.USD","IE0002270589.USD","IE00BD4GTW91.USD","LU0330918003.SGD","IE0034235303.USD","IE00BMPRXQ63.HKD","LU2271345857.HKD","LU1979441026.SGD","LU0070217475.USD","LU0203202063.USD","BK4515","IE00BVYPNQ40.USD","LU0823414478.USD","LU1720051108.HKD","LU1037948541.HKD","LU0347712357.USD","LU1235294995.USD","LU2298321311.HKD","NVC","LU1551013342.USD","LU0143863784.USD","LU1934455863.HKD","LU2237443622.USD","LU1923622291.USD","LU1057294990.SGD","LU1223083913.SGD","IE00B3S45H60.SGD","LU0494093205.USD","LU1064131342.USD","LU1983260115.SGD","LU2417539215.USD","LU1084165304.USD","SG9999002224.SGD","BK4543","LU0048573561.USD","LU0276348264.USD","LU0211328371.USD","LU0354030511.USD","LU1267930730.SGD","LU1642822529.SGD","LU2750360641.GBP","SOXQ","LU2083900584.USD","IE00BQXX3C00.GBP","LU1119994496.HKD","LU1880398471.USD","SMHX","BK4512","LU0979878070.USD","ADBU","AVGO","LU0130518102.USD","LU0784384876.USD","LU1623119135.USD","LU0130103400.USD","TEK","LU2756315318.SGD","LU0107464264.USD","LU1066053197.SGD","AVGU","LU0496367417.USD","LU2596442595.SGD","LU2125154778.USD","CRM","BK4579","LU2095319765.USD","LU2211814178.USD","LU2272731600.USD","BK4612","BK4007","IE00B4YYXB79.USD","IE00BYQQ9H92.USD","AVGX","SNOU","LU0082616367.USD","LU2413666426.HKD","NOWX","LU1868836914.USD","BK4505","BK4533","SG9999017495.SGD","BK4139","BK4532","ESUM","LU1571399168.USD","AVGC","LU0130517989.USD","LU2168564065.EUR","LU2552382132.HKD","SG9999018857.SGD","LU0345770308.USD","LU1989772840.SGD","IE00B7KXQ091.USD","FAI","IE00B775SV38.USD","BK4599","HMY","LU2089283258.USD","LU1868837300.USD","SGXZ23171101.USD","IE00BDCRKT87.USD","LU2463028550.USD","LU0985320562.USD","IE00B64PRP62.GBP","LU0061474705.USD","NWMX","LU0943347566.SGD","BX","IE00BYXW3230.USD","LU0648000940.SGD","LU0868494708.USD","LU2471134952.CNY","NVD2.UK","LU1035775433.USD","LU1988902786.USD","LU3102509885.SGD","NVDA","LU0661504455.SGD","LU0061474960.USD","LU1674673428.USD","LU0787776722.HKD","SHOC","LU2491050071.SGD","LU0109392836.USD","LU0303821028.USD","ALB","IE0004086264.USD","LU1267930490.SGD","LU2471134523.USD","LU1868837565.USD","LU0444973449.USD","LU0274383776.USD","XLK","BK4081","LU2272731865.HKD","LU2487616109.SGD","LU2125909759.SGD","09388","LU2637965513.SGD","LU2077746001.SGD","IE000YTNTUN2.SGD","LU2471134796.USD","LU1803068623.USD","PCG","BK4135","LU1803068979.SGD","LU0683600562.USD","LU1880398554.USD","IDRV","LU0310800379.SGD","LU2449327464.USD","IE00BGHQF748.EUR","CMAG","NVD3.UK","LU0472753341.HKD","LU1121112475.USD","LU0689626769.HKD","IE00BLSP4239.USD","LU1674673691.USD","LU1914381329.SGD","LU0251131958.USD","LU1935042215.USD","LU1699723380.USD","LU1923622614.USD","LU2111349929.HKD","LU2272731782.SGD","BK4094","HPE","SGXZ80539844.SGD","LU2237957811.SGD","IE0001KFT4U8.USD","BK4588","LU0957791311.USD","LU0980610538.SGD","LU0949170426.SGD","GLDN","LU0225771236.USD","LU0345768740.USD","LU1868836591.USD","LU1400636574.HKD","IE00BHPRN162.USD","LU0654597011.USD","LU0726765562.USD","LU2860962120.EUR","07788","LU0889565833.HKD","LU1894683348.USD","LU2244417387.USD","SG9999001424.SGD","LU0823414551.USD","OZEM","LU2191332357.HKD","LU1670710588.SGD","NVDO","AAUM","LU0072462426.USD","IE00BBT3K403.USD","LU1720051017.SGD","LU1236620750.USD","LU2355687059.USD","SG9999001143.SGD","LU0029864427.USD","LU0630314457.HKD","LU0642271901.SGD","LU2242649171.HKD","IE00BZ1G4Q59.USD","PRVT","LU1633808545.USD","HK0000320264.USD","LU1629891620.HKD","GOAU","LU2237443549.SGD","LU0820561909.HKD","TTEQ","IE0004091025.USD","LU0278409577.USD","LU1868836757.USD","LU0345768153.USD","SG9999014880.SGD","LU0964807845.USD","LU1244550494.USD","LU0323240290.USD","IE0003U64NQ7.SGD","IE000ITXATA3.USD","IETC","LU0426412945.USD","BK4559","IE00BN29S564.USD","LU0203345920.USD","LU2552382058.USD","REMX","LU1861214812.USD","BK4122","HPEL","BK4575","LU0994945656.USD","SLVP","AVS","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159628812","title":"Medicus Pharma盘前股价大跌20.5%，与辉瑞达成实验性癌症疗法授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1159628812","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159628812?lang=zh_cn&edition=fundamental","pubTime":"2026-09-03 21:04","pubTimestamp":1788440685,"startTime":"0","endTime":"0","summary":"Medicus Pharma股价在盘前交易时段重挫20.5%。与此同时，该公司宣布与制药巨头辉瑞签署了一项授权协议，涉及一款尚处于实验阶段的癌症治疗药物。这一消息引发市场剧烈反应，投资者对该合作协议的条款及潜在影响迅速作出评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","BK4581","BK4568","LU0456855351.SGD","LU0985481810.HKD","LU0225771236.USD","OZEM","LU1066051498.USD","PFE","SG9999011175.SGD","SG9999001176.SGD","LU1894683348.USD","SG9999002232.USD","IE00BLSP4452.SGD","IE00B19Z3581.USD","LU0306807586.USD","BK4585","BK4588","LU0225284248.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4533","LU0170899867.USD","LU0289739699.SGD","SG9999001176.USD","SG9999002224.SGD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU2596442595.SGD","BK4534","IE0002270589.USD","BK4007","IE000M9KFDE8.USD","BK4599","LU1066053197.SGD","MDCX","SGXZ57979304.SGD","LU0058720904.USD","LU1894683264.USD","BK4550","LU0234572021.USD","LU0122379950.USD","BK4139","LU0306806265.USD","LU1883839398.USD","IE00BBT3K403.USD","IE00B3T34201.USD","LU0868494617.USD","SG9999013999.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874185","title":"Medicus Pharma股价飙升，因与辉瑞达成实验性癌症疗法授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874185","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874185?lang=zh_cn&edition=fundamental","pubTime":"2026-09-03 20:26","pubTimestamp":1788438376,"startTime":"0","endTime":"0","summary":"BUZZ-Medicus Pharma股价飙升，因与辉瑞达成实验性癌症疗法授权协议9月3日-** 制药公司Medicus Pharma（MDCX.O）的股价在盘前交易中飙升19.3%，至31美分** 该公司在监管文件中表示，已与辉瑞（Pfizer，PFE.N）签署许可协议，获得一项实验性癌症疗法的开发和商业化权利** 根据协议，辉瑞有资格获得超过10亿美元的研发、监管及销售里程碑付款，以及基于净销","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4S44V0YL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","IE00BLSP4239.USD","SG9999001176.USD","SG9999001176.SGD","BK4585","LU2596442595.SGD","OZEM","LU1023059063.AUD","BK4534","LU0306807586.USD","LU0321505868.SGD","LU1057294990.SGD","IE00B19Z3581.USD","PFE","SG9999002232.USD","LU0225284248.USD","SG9999013999.USD","IE00B19Z3B42.SGD","BK4550","LU0289739699.SGD","BK4007","LU0170899867.USD","LU0306806265.USD","BK4599","BK4568","BK4581","LU1883839398.USD","LU0321505439.SGD","LU0868494617.USD","LU0122379950.USD","LU0058720904.USD","LU0456855351.SGD","LU0234572021.USD","LU0985481810.HKD","SG9999002224.SGD","IE0002270589.USD","BK4139","LU1066051498.USD","SGXZ57979304.SGD","SG9999003800.SGD","LU0225771236.USD","LU1066053197.SGD","IE00BBT3K403.USD","BK4533","LU1894683264.USD","MDCX","BK4588","LU1894683348.USD","SG9999011175.SGD","IE000M9KFDE8.USD","IE00B3T34201.USD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187458964","title":"Medicus Pharma于2026年9月2日与辉瑞签署共同开发及许可协议——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1187458964","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187458964?lang=zh_cn&edition=fundamental","pubTime":"2026-09-03 20:06","pubTimestamp":1788437176,"startTime":"0","endTime":"0","summary":"2026年9月2日，Medicus Pharma与制药巨头辉瑞达成了一项共同开发及许可协议。这一消息源自该公司向美国证券交易委员会提交的官方文件。\n根据SEC文件显示，Medicus Pharma于当日正式与辉瑞签署合作协议。然而，文件并未详细披露该协议的具体条款及涉及的药物领域，外界对此充满猜测。\n投资者正密切关注这一合作动态，Medicus Pharma的此次战略布局也被视为其发展的重要里程碑。辉瑞作为全球领先的制药企业，选择与Medicus Pharma联手，无疑为后者注入了强劲的发展动力。\n关于该合作协议的更多细节，尚待双方进一步公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4592","SG9999003800.SGD","IE0002270589.USD","SG9999001176.USD","LU1883839398.USD","LU0225771236.USD","IE000M9KFDE8.USD","BK4139","LU0234572021.USD","IE00BLSP4239.USD","BK4581","LU0225284248.USD","LU0321505439.SGD","PFE","LU1023059063.AUD","SG9999001176.SGD","BK4533","SG9999011175.SGD","LU0868494617.USD","BK4007","BK4550","LU0122379950.USD","LU1066051498.USD","SGXZ57979304.SGD","BK4534","BK4599","BK4568","IE00B19Z3581.USD","LU0289739699.SGD","SG9999002232.USD","BK4588","LU1894683264.USD","LU0306806265.USD","MDCX","LU1066053197.SGD","LU2596442595.SGD","LU0321505868.SGD","LU0456855351.SGD","LU0985481810.HKD","LU0170899867.USD","IE00BBT3K403.USD","BK4585","IE00B3T34201.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU1894683348.USD","SG9999013999.USD","OZEM","LU0306807586.USD","SG9999002224.SGD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107772972","title":"新闻稿：Medicus Pharma 任命 Faisal Mehmud 博士为英国子公司 Antev Limited 首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1107772972","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107772972?lang=zh_cn&edition=fundamental","pubTime":"2026-08-03 19:33","pubTimestamp":1785756837,"startTime":"0","endTime":"0","summary":"费城，2026年8月3日——生物科技与生命科学公司 Medicus Pharma Ltd.今日宣布，任命Faisal Mehmud医学博士、皇家内科医师学会会员为英国子公司Antev Limited的首席执行官，自2026年8月30日起生效。该公司专注于推进新型且潜在颠覆性治疗资产的临床开发项目。Mehmud博士将继续担任Medicus的首席医疗官和Antev的联合主席。此次任命进一步加强了Medicus的整合领导架构。Mehmud博士接替了Amit Kohli，后者自2025年8月29日Medicus完成对Antev的收购以来一直担任临时首席执行官。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4232","BK4567","BK4233","BK4211","BK4205","UBCP","UK","BK4139","BK4022","BCC","BK4528","MDCX","MRCP","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127932291","title":"Medicus Pharma任命DR. Faisal Mehmud为英国Antev Limited首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1127932291","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127932291?lang=zh_cn&edition=fundamental","pubTime":"2026-08-03 19:31","pubTimestamp":1785756684,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.（简称Medicus Pharma）正式宣布，已任命DR. Faisal Mehmud担任其旗下位于英国的子公司Antev Limited的首席执行官一职。这一重要人事变动，标志着公司在全球战略布局中迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177582386","title":"Medicus Pharma获阿联酋卫生部门批准，推进Teverelix Precision-E2 2a期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1177582386","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177582386?lang=zh_cn&edition=fundamental","pubTime":"2026-07-31 19:31","pubTimestamp":1785497475,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.宣布，阿联酋卫生部门已正式批准其开展Teverelix的Precision-E2 2a期临床研究。这一授权标志着该药物研发进程中的重要里程碑。获批的临床试验将聚焦于评估Teverelix的疗效与安全性，为后续研究奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149302811","title":"Medicus Pharma 获FDA批准：针对戈林综合征患者的Skinject®关键注册研究可启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1149302811","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149302811?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 20:18","pubTimestamp":1785154690,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.（MDCX）近日迎来重大里程碑——美国食品药品监督管理局（FDA）已正式发出“研究可推进”函件，为其针对戈林综合征患者的NDA注册性Skinject®研究亮起绿灯。这一关键进展，标志着该药物的临床开发迈入新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153699376","title":"Medicus Pharma获FDA积极反馈及中心IRB批准，开展优化版Teverelix®治疗急性尿潴留二期新研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1153699376","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153699376?lang=zh_cn&edition=fundamental","pubTime":"2026-07-16 19:31","pubTimestamp":1784201518,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.宣布，其针对急性尿潴留的优化版Teverelix®二期新研究已获得美国食品药品监督管理局（FDA）的积极反馈以及中心机构审查委员会（IRB）的批准。这一关键进展标志着该创新疗法向临床开发迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126634681","title":"Medicus Pharma宣布向美国食品药品监督管理局提交Skinject®用于戈林综合征的罕见儿科疾病认定申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1126634681","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126634681?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 19:31","pubTimestamp":1781523074,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.（MDCX）已正式向美国食品药品监督管理局（FDA）提交申请，为其在研产品Skinject®寻求戈林综合征适应症的罕见儿科疾病认定。这一认定若获批准，将有望为患有此种罕见遗传性皮肤疾病的儿童患者带来新的治疗希望，并可能使公司在后续的研发与商业化进程中享有相应的政策激励。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103137641","title":"Medicus Pharma启动基于阿联酋基因组计划的突破性Teverelix®治疗子宫内膜异位症的Precision-E2 IIa期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1103137641","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103137641?lang=zh_cn&edition=fundamental","pubTime":"2026-06-11 19:31","pubTimestamp":1781177506,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd. (MDCX) 宣布启动一项具有开创性的Precision-E2 IIa期临床研究，该研究将利用阿联酋基因组计划的数据，评估其候选药物Teverelix®在治疗子宫内膜异位症方面的疗效与安全性。这项研究标志着该公司在精准医疗领域迈出了重要一步，旨在通过基因组信息为患者提供更个体化的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110064382","title":"Medicus Pharma推进Teverelix®项目进入注册开发阶段，针对高心血管风险前列腺癌患者完成关键欧洲提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1110064382","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110064382?lang=zh_cn&edition=fundamental","pubTime":"2026-06-08 19:33","pubTimestamp":1780918414,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd. 已将其Teverelix项目推进至注册开发阶段，旨在针对伴有高心血管风险的前列腺癌患者。这一进展的关键标志是公司已向欧洲监管机构提交了关键文件。Teverelix项目专注于满足这一特定患者群体的医疗需求，他们因心血管并发症风险较高，在治疗选择上面临更大挑战。下一步，公司将与监管机构密切合作，以确定后续的开发路径。这一战略举措有望为Medicus Pharma在该治疗领域建立重要地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113733033","title":"Medicus Pharma公布预设扩展二期Sknjct-003数据分析结果 显示显著剂量效应","url":"https://stock-news.laohu8.com/highlight/detail?id=1113733033","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113733033?lang=zh_cn&edition=fundamental","pubTime":"2026-05-06 19:37","pubTimestamp":1778067449,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.最新披露的预设扩展二期临床试验Sknjct-003数据分析结果证实，其研究药物存在明确的剂量-效应关系。该数据进一步验证了治疗方案的有效性，为后续临床开发提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107238761","title":"Medicus Pharma Ltd. 旗下D-Mna展现良好安全性特征 未出现药物相关严重不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1107238761","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107238761?lang=zh_cn&edition=fundamental","pubTime":"2026-05-06 19:34","pubTimestamp":1778067254,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd. 近日公布其研究药物D-Mna的临床试验数据，结果显示该药物表现出良好的安全性特征。在整个试验过程中，未观察到任何与药物相关的严重不良事件。\n这一积极数据为D-Mna的后续临床开发奠定了坚实基础，凸显了其在安全性方面的显著优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169937282","title":"Medicus制药公司提交SEC文件：拟通过代理机构发行不超过5000万美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1169937282","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169937282?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 05:13","pubTimestamp":1776978807,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会（SEC）的文件显示，Medicus制药有限公司计划通过指定代理机构，以公开发行的方式出售普通股，募集资金总额最高可达5000万美元。\n该文件表明，公司可能根据市场条件、股价波动等因素，一次或分多次进行股份发售。此次融资方案将为Medicus制药提供额外的运营资本，以支持其业务发展和战略计划的推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}